Biolife Solutions
BLFS
Biolife Solutions (BLFS) - Cash on Hand
Cash on Hand as of December 2023 : $51.69 M
According to Biolife Solutions
's latest financial reports the company has $51.69 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biolife Solutions - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $51.69 M | -17.55% |
| 2022-12-31 | $62.7 M | -10.25% |
| 2021-12-31 | $69.86 M | -22.72% |
| 2020-12-31 | $90.4 M | 1302.03% |
| 2019-12-31 | $6.44 M | -78.97% |
| 2018-12-31 | $30.65 M | 360.11% |
| 2017-12-31 | $6.66 M | 373.96% |
| 2016-12-31 | $1.4 M | -63.24% |
| 2015-12-31 | $3.82 M | -61.52% |
| 2014-12-31 | $9.93 M | 6259.64% |
| 2013-12-31 | $0.15 M | -20.46% |
| 2012-12-31 | $0.19 M | 1065.07% |
| 2011-12-31 | $0.01 M | 425.19% |
| 2010-12-31 | $0 M | -97.69% |
| 2009-12-31 | $0.13 M | 40.95% |
| 2008-12-31 | $0.09 M | 74.74% |
| 2007-12-31 | $0.05 M | -52.39% |
| 2006-12-31 | $0.11 M | -35.88% |
| 2005-12-31 | $0.18 M | -65.19% |
| 2004-12-31 | $0.53 M | -32.52% |
| 2003-12-31 | $0.78 M | 1073.91% |
| 2002-12-31 | $0.06 M | -76.54% |
| 2001-12-31 | $0.28 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Celanese CE | $1.80 B | 3,391.63% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.33 B | 552.19% | 🇺🇸 USA |
 Amyris AMRS | $11.24 M | -78.25% | 🇺🇸 USA |